DE60104670D1 - Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten - Google Patents
Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthaltenInfo
- Publication number
- DE60104670D1 DE60104670D1 DE60104670T DE60104670T DE60104670D1 DE 60104670 D1 DE60104670 D1 DE 60104670D1 DE 60104670 T DE60104670 T DE 60104670T DE 60104670 T DE60104670 T DE 60104670T DE 60104670 D1 DE60104670 D1 DE 60104670D1
- Authority
- DE
- Germany
- Prior art keywords
- lacrophyl
- active substance
- active components
- therapeutically active
- eye drops
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003889 eye drop Substances 0.000 title abstract 3
- 229940012356 eye drops Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 102000016943 Muramidase Human genes 0.000 abstract 1
- 108010014251 Muramidase Proteins 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 229960001484 edetic acid Drugs 0.000 abstract 1
- 235000010335 lysozyme Nutrition 0.000 abstract 1
- 229960000274 lysozyme Drugs 0.000 abstract 1
- 239000004325 lysozyme Substances 0.000 abstract 1
- 230000002906 microbiologic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0001769A HUP0001769A2 (hu) | 2000-05-04 | 2000-05-04 | Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben |
| HU0001769 | 2000-05-04 | ||
| PCT/HU2001/000053 WO2001082893A1 (en) | 2000-05-04 | 2001-05-04 | Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60104670D1 true DE60104670D1 (de) | 2004-09-09 |
| DE60104670T2 DE60104670T2 (de) | 2005-01-13 |
Family
ID=89978306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2001604670 Expired - Lifetime DE60104670T2 (de) | 2000-05-04 | 2001-05-04 | Verwendung eines lacrophilen Präparats in Augentropfen, die therapeutische Komponenten enthalten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6949241B2 (de) |
| EP (1) | EP1278511B1 (de) |
| AT (1) | ATE272389T1 (de) |
| AU (1) | AU2001258662A1 (de) |
| CA (1) | CA2407794A1 (de) |
| DE (1) | DE60104670T2 (de) |
| ES (1) | ES2248326T3 (de) |
| HU (1) | HUP0001769A2 (de) |
| WO (1) | WO2001082893A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040229814A1 (en) * | 2002-08-28 | 2004-11-18 | James Dillon | Methods and compositions for protecting against cataract development associated with vitrectomies |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US20060275278A1 (en) * | 2005-06-02 | 2006-12-07 | Choy Camus K M | Method and ophthalmic formulation for eye protection or treatment |
| WO2007130364A2 (en) * | 2006-05-01 | 2007-11-15 | Riolan Technologies, Inc. | Compositions, methods, and kits for treating dry eye |
| EP2134355A4 (de) * | 2007-03-02 | 2012-01-11 | Saint Simeon Lda | Neue ophthalmische zusammensetzungen mit humanem rekombinantem lysozym und ihre verwendung zur behandlung von augenerkrankungen und als kontaktlinsenlösungen |
| CN103182075B (zh) * | 2011-12-30 | 2015-07-22 | 沈阳兴齐眼药股份有限公司 | 一种溶菌酶制剂、其制备方法及用途 |
| JP6867288B2 (ja) * | 2014-07-21 | 2021-04-28 | エーエムディー セラピューティックス エルエルシー | リファマイシンの眼科用組成物およびその使用 |
| EP3217807A4 (de) | 2014-11-11 | 2018-09-12 | Clara Foods Co. | Verfahren und zusammensetzungen zur herstellung von eiweissproteinen |
| WO2017209721A1 (en) | 2016-06-02 | 2017-12-07 | Alemdar Eda | A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation |
| HRP20250315T1 (hr) | 2019-07-11 | 2025-06-06 | Clara Foods Co. | Sastav napitka koji sadrži rekombinantni protein ovomukoid |
| US12096784B2 (en) | 2019-07-11 | 2024-09-24 | Clara Foods Co. | Protein compositions and consumable products thereof |
| US10927360B1 (en) | 2019-08-07 | 2021-02-23 | Clara Foods Co. | Compositions comprising digestive enzymes |
| WO2022138639A1 (ja) * | 2020-12-21 | 2022-06-30 | ビーエヌシー コリア カンパニー，リミテッド | リファマイシンの眼科用組成物およびその使用 |
| US12005093B2 (en) * | 2022-08-11 | 2024-06-11 | Hong Kong Chinese Medicine Ophthalmology Institute Limited | Traditional chinese medicine eye drops and the preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
| US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
| HU209538B (en) * | 1990-05-09 | 1994-07-28 | Vepex Contractor Ltd | Set and cleaning composition for treating contactlenses |
-
2000
- 2000-05-04 HU HU0001769A patent/HUP0001769A2/hu unknown
-
2001
- 2001-05-04 EP EP01931980A patent/EP1278511B1/de not_active Expired - Lifetime
- 2001-05-04 ES ES01931980T patent/ES2248326T3/es not_active Expired - Lifetime
- 2001-05-04 AT AT01931980T patent/ATE272389T1/de not_active IP Right Cessation
- 2001-05-04 US US10/275,125 patent/US6949241B2/en not_active Expired - Fee Related
- 2001-05-04 DE DE2001604670 patent/DE60104670T2/de not_active Expired - Lifetime
- 2001-05-04 CA CA002407794A patent/CA2407794A1/en not_active Abandoned
- 2001-05-04 WO PCT/HU2001/000053 patent/WO2001082893A1/en not_active Ceased
- 2001-05-04 AU AU2001258662A patent/AU2001258662A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE272389T1 (de) | 2004-08-15 |
| WO2001082893A1 (en) | 2001-11-08 |
| EP1278511B1 (de) | 2004-08-04 |
| EP1278511A1 (de) | 2003-01-29 |
| HU0001769D0 (en) | 2000-07-28 |
| ES2248326T3 (es) | 2006-03-16 |
| CA2407794A1 (en) | 2001-11-08 |
| AU2001258662A1 (en) | 2001-11-12 |
| US20030124112A1 (en) | 2003-07-03 |
| HUP0001769A2 (hu) | 2002-01-28 |
| US6949241B2 (en) | 2005-09-27 |
| DE60104670T2 (de) | 2005-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60104670D1 (de) | Verwendung einer lacrophyl zubereitung in augentropfen, die therapeutisch wirksame komponenten enthalten | |
| CL2010000606A1 (es) | Uso de derivados de eritropoyetina en la preparacion de un medicamento util para proteger, mantener, mejorar o recuperar la viabilidad de celulas que responden a eritropoyetina en condiciones anomalas que afectan las celulas, tejidos u organos asociados; derivados de eritropoyetinas y composicion que las comprende (divisional de la solicitud 3188-2001). | |
| AU2525401A (en) | Use of an extract of at least one vaccinium-type plant as an anti-glycation agent | |
| DE69524772D1 (de) | Ophthalmologisches abgabesystem | |
| ATE321533T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen | |
| NO981539D0 (no) | Gelformuleringer inneholdende vekstfaktorer | |
| CA2182576A1 (en) | Bilayer preparations | |
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| BR0113477A (pt) | Peptìdios de penetração em membranas e usos dos mesmos | |
| NO20001042L (no) | Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter | |
| FI970788A0 (fi) | Kasveilla käytettäviksi tarkoitettuja suihkutettavissa olevia, kalvon muodostavia järjestelmiä vaikuttavien aineiden antamiseksi | |
| EP1319402A4 (de) | IgE-ENTSTEHUNGSHEMMSTOFFE | |
| ITMI20020189A1 (it) | Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli | |
| BR9914644A (pt) | Composições tamponadas para diálise | |
| DK0413793T3 (da) | Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet | |
| AU2001278708A1 (en) | Adenosine derivatives and use thereof | |
| ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
| EA199800435A1 (ru) | Пестицидный препарат | |
| HUP0101177A2 (hu) | Glikogén alkalmazása mesterséges könnyként felhasználható oldat előállítására | |
| ATE83668T1 (de) | Pflaster zur transdermalen anwendung. | |
| TR200201148T2 (tr) | Haşerat ilacı terkipleri ve metodları. | |
| MD1762B2 (ro) | Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile | |
| TR199701617T1 (xx) | �iftliklerde �retilen bal�klarda g�r�len parazitlerle m�cadelede kullan�lacak bir ajan. | |
| EP0175490A3 (de) | Zusammensetzungen zur Behandlung von Kontaktlinsen und ihre Anwendung | |
| SE9302203D0 (sv) | Composition for ophthalmic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |